Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

Total article views   Abstract views HTML views PDF downloads Totals
12,568 Dovepress* 9,484 1,533+ 1,336 11,017
PubMed Central* 0 1,551 728 1,551
Totals 9,484 3,084 2,064 12,568
*Since 6 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
22 1 0 0 9 12

View citations on PubMed Central and Google Scholar